Freestone Capital Holdings’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.98M Buy
11,312
+81
+0.7% +$28.9K 0.12% 122
2025
Q4
$3.68M Buy
11,231
+149
+1% +$47.3K 0.11% 127
2025
Q3
$3.13M Buy
11,082
+617
+6% +$179K 0.1% 138
2025
Q2
$2.92M Sell
10,465
-1,198
-10% -$339K 0.1% 136
2025
Q1
$3.63M Sell
11,663
-1,385
-11% -$409K 0.14% 115
2024
Q4
$3.4M Sell
13,048
-139
-1% -$41.2K 0.12% 118
2024
Q3
$4.25M Sell
13,187
-69
-0.5% -$22.6K 0.15% 106
2024
Q2
$4.14M Buy
13,256
+577
+5% +$170K 0.15% 102
2024
Q1
$3.6M Sell
12,679
-97
-0.8% -$28.4K 0.13% 116
2023
Q4
$3.68M Sell
12,776
-218
-2% -$59.4K 0.17% 104
2023
Q3
$3.49M Buy
12,994
+316
+2% +$78.9K 0.18% 98
2023
Q2
$2.81M Sell
12,678
-827
-6% -$192K 0.11% 124
2023
Q1
$3.26M Sell
13,505
-268
-2% -$65.8K 0.14% 105
2022
Q4
$3.62M Sell
13,773
-4,936
-26% -$1.32M 0.17% 96
2022
Q3
$4.22M Sell
18,709
-5,893
-24% -$1.43M 0.19% 81
2022
Q2
$5.99M Sell
24,602
-6,272
-20% -$1.54M 0.23% 71
2022
Q1
$7.47M Sell
30,874
-557
-2% -$128K 0.3% 73
2021
Q4
$7.07M Sell
31,431
-1,271
-4% -$268K 0.3% 71
2021
Q3
$6.95M Sell
32,702
-8,074
-20% -$1.86M 0.35% 69
2021
Q2
$9.94M Buy
40,776
+20
+0% +$4.92K 0.5% 43
2021
Q1
$10.1M Sell
40,756
-4,237
-9% -$1.01M 0.55% 38
2020
Q4
$10.3M Buy
44,993
+2,242
+5% +$517K 0.6% 31
2020
Q3
$10.9M Buy
42,751
+1,113
+3% +$276K 0.71% 28
2020
Q2
$9.82K Buy
41,638
+1,172
+3% +$267K 0.12% 36
2020
Q1
$8.2K Sell
40,466
-6,502
-14% -$1.42M 0.18% 37
2019
Q4
$11.3K Buy
46,968
+7,894
+20% +$1.74M 0.23% 27
2019
Q3
$7.56K Buy
39,074
+49
+0.1% +$9.4K 0.18% 39
2019
Q2
$7.19K Sell
39,025
-49,211
-56% -$8.81M 0.18% 54
2019
Q1
$16.8M Sell
88,236
-26,640
-23% -$5.09M 0.99% 19
2018
Q4
$22.4M Sell
114,876
-8,899
-7% -$1.74M 1.51% 12
2018
Q3
$25.7M Sell
123,775
-84
-0.1% -$16.6K 0.16% 14
2018
Q2
$22.9M Buy
123,859
+77,225
+166% +$13.7M 0.14% 18
2018
Q1
$7.95M Buy
46,634
+9,487
+26% +$1.74M 0.46% 60
2017
Q4
$6.46M Buy
37,147
+3,877
+12% +$686K 0.45% 58
2017
Q3
$6.2M Buy
33,270
+987
+3% +$175K 0.44% 60
2017
Q2
$5.56M Sell
32,283
-528
-2% -$85.9K 0.43% 54
2017
Q1
$5.38M Buy
32,811
+2,368
+8% +$393K 0.42% 48
2016
Q4
$4.45M Buy
30,443
+21,751
+250% +$3.27M 0.38% 55
2016
Q3
$1.45M Buy
8,692
+2,120
+32% +$358K 0.13% 146
2016
Q2
$1M Sell
6,572
-208
-3% -$32.3K 0.1% 166
2016
Q1
$1.02M Buy
6,780
+12
+0.2% +$1.78K 0.11% 163
2015
Q4
$1.1M Buy
+6,768
New +$1.06M 0.11% 153
2015
Q2
Sell
-1,355
Closed -$217K 226
2015
Q1
$217K Hold
1,355
0.03% 162
2014
Q4
$216K Buy
+1,355
New +$211K 0.04% 160
2013
Q3
Sell
-13,400
Closed -$1.32M 362
2013
Q2
$1.32M Buy
+13,400
New +$1.39M 0.27% 53

Other funds holding AMGN

Freestone Capital Holdings's AMGN Position: Q1 2026 in Review

Freestone Capital Holdings increased its Amgen (AMGN) stake by 0.72% in Q1 2026, buying an estimated $28.9K and bringing the position to 11,312 shares worth $3.98M. The position accounts for 0.12% of the portfolio, ranked #122.

Freestone Capital Holdings first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $25.7M in Q3 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Freestone Capital Holdings held 11,312 shares of Amgen worth $3.98M as of Q1 2026.
  • Freestone Capital Holdings bought 81 Amgen shares in Q1 2026, an estimated $28.9K.
  • Amgen made up 0.12% of Freestone Capital Holdings's portfolio in Q1 2026, its #122 holding.
  • Freestone Capital Holdings first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
  • Freestone Capital Holdings's Amgen position peaked at $25.7M in Q3 2018.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.